Trending

    Marty Makary resigns as FDA Commissioner after 13 months of controversy

    Section editor: ·Low6 articles covering this·6 news sources·Updated a month ago·World
    Share:
    Dr. Marty Makary speaking at a press conference as FDA Commissioner

    Here's what it means for you.

    The resignation of Dr. Marty Makary signals potential shifts in U.S. health policy and regulatory approaches.

    What happened

    Dr. Marty Makary has resigned from his position as FDA Commissioner after a tumultuous period in office.

    The Context

    • Clashes with the Trump administration: Makary's tenure was characterized by significant disagreements with the White House.
    • Opposition to flavored vapes: He opposed the approval of flavored vapes, conflicting with industry interests.
    • Controversial health issues: His resignation follows a series of controversies involving the FDA's handling of various health matters.

    Takeaway

    The FDA will likely undergo further changes as the administration seeks to address ongoing health and regulatory challenges.

    6 Articles
    International Business Times

    FDA Commissioner Marty Makary Resigns After Clashes With White House

    Dr. Marty Makary has resigned from his position as the U.S. Food and Drug Administration Commissioner after a challenging 13-month tenure marked by conflicts with the White House. His resignation comes amid reports of potential dismissal by former Pr...

    WSJ Tech

    Embattled Commissioner Makary to Leave FDA

    Commissioner Makary is set to leave the FDA amid ongoing scrutiny of the agency's leadership and effectiveness. This decision comes as the FDA faces criticism over its handling of various health-related issues and regulatory processes.

    NPR

    FDA commissioner resigns after tumultuous tenure

    Dr. Marty Makary has resigned as the commissioner of the Food and Drug Administration (FDA), concluding a tumultuous tenure characterized by significant challenges and controversies. His departure follows increasing dissatisfaction from President Don...

    The New York Times

    Marty Makary, Trump’s F.D.A. Commissioner, Resigns After Weeks of Pressure

    Dr. Marty Makary has resigned as the Commissioner of the U.S. Food and Drug Administration (FDA) following weeks of pressure from former President Trump, who had been critical of the FDA's regulatory decisions, particularly regarding flavored vape pr...

    The New York Times

    Marty Makary, Trump’s F.D.A. Commissioner, Resigns After Weeks of Pressure

    Dr. Marty Makary has resigned as the Commissioner of the U.S. Food and Drug Administration (FDA) following weeks of pressure from former President Trump, who had been critical of the FDA's regulatory decisions, particularly regarding flavored vape pr...

    The New York Times

    Marty Makary, Trump’s F.D.A. Commissioner, Resigns After Weeks of Pressure

    Dr. Marty Makary has resigned as the Commissioner of the U.S. Food and Drug Administration (FDA) following weeks of pressure from former President Trump, who had been critical of the FDA's regulatory decisions, particularly regarding flavored vape pr...

    Scientific American — Global

    Trump’s FDA Commissioner Marty Makary resigns

    Marty Makary has resigned as FDA Commissioner, a role he held under former President Trump, where he was a prominent figure in the administration's health initiatives, particularly concerning vaping and abortion issues.

    Scientific American

    Trump’s FDA Commissioner Marty Makary resigns

    Marty Makary has resigned as FDA Commissioner, a role he held under former President Trump, where he was a prominent figure in the administration's health initiatives, particularly concerning vaping and abortion issues.

    Forbes

    FDA Commissioner Marty Makary Resigns—Trump Refuses To Say Whether He Fired Him

    FDA Commissioner Dr. Marty Makary has resigned amid reports that former President Trump was considering firing him, reflecting ongoing tensions between the Trump administration and the FDA regarding regulatory policies.